Fiche publication
Date publication
mai 2026
Journal
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LEPAGE Côme
,
Dr COTTET Vanessa
,
Pr MANFREDI Sylvain
Tous les auteurs :
Monbet V, Raoul W, Emond P, Gueguinou M, Lefevre A, Dolly A, Anon B, Dorval E, Chautard R, Cottet V, Lepage C, Manfredi S, Blasco H, Lecomte T, Sire O
Lien Pubmed
Résumé
Colorectal cancer (CRC) is a major health burden, the third most common cancer and the second leading cause of cancer-related death worldwide. The development of biomarkers for screening, diagnosis, prognosis and prediction is crucial for early management and treatment of CRC. Despite existing biomarkers, particularly tests targeting alterations in DNA, proteins other than hemoglobin or other molecules in biological samples, there is a need for new, comprehensive and minimally invasive assays that reflect neoplastic biology.
Mots clés
Colorectal cancer, MIR spectrometry, Metabolomics, Multi-modal data, Risk stratification, Statistical pipeline
Référence
Spectrochim Acta A Mol Biomol Spectrosc. 2026 05 8;360:128025
